2 completed, 1 recruiting, 1 terminated. 3 Phase 4, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 3 | Completed 1, Recruiting 1, Terminated 1 |
| Phase 3 | 1 | Completed 1 |
Follow Losartan 50 mg: new trials by email Literature Review of Losartan 50 mg trials Research Report on Losartan 50 mg
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Effect of Losartan on the Neurohumoral Axis and Ventricular Remodeling of Patients With Severe Aortic Regurgitation Undergoing Valve Surgery. Losartan 50 mg, Placebo - Heart Valve Diseases, Left Ventricle Remodeling | Phase 4 | Recruiting | Vitor Emer Egypto Rosa | 60 | 2025-07-01 | 2025-08-01 |
| Effect of Losartan on Airway Mucociliary Dysfunction in Patients With COPD and Chronic Bronchitis Losartan 50 mg, Losartan 100 mg - COPD, Chronic Bronchitis | Phase 4 | Terminated | University of Miami | 31 | 2016-03-31 | 2020-08-20 |
| Telmisartan and Losartan in Hypertensive IGT Telmisartan 80 mg, Losartan 50 mg - Hypertension, Impaired Glucose Tolerance | Phase 4 | Completed | Medical University of Graz | 24 | 2005-01-01 | 2006-12-05 |
| Study to Evaluate Potential Decrease in Hospitalization Events, Time Between Events, and Increasing Longevity in Patients With Symptomatic Heart Failure (0954-948) Losartan 50 mg, Losartan 150 mg - Heart Failure | Phase 3 | Completed | Organon and Co | 3834 | 2001-12-19 | 2024-05-16 |
Heart Failure (2) · Aortic Valve Insufficiency (1) · Bronchitis, Chronic (1) · Glucose Intolerance (1) · Heart Valve Diseases (1) · Hypertension (1) · Insulin Resistance (1) · Pulmonary Disease, Chronic Obstructive (1) · Ventricular Remodeling (1)
Medical University of Graz (1) · Organon and Co (1) · University of Miami (1) · Vitor Emer Egypto Rosa (1)
Austria (1) · Brazil (1) · United States (1)
Rafael Calderon, MD (1) · Thomas C. Wascher, MD (1) · Vitor E. E. Rosa, MD, PhD (1)
PMID 19922995, PMID 25742759, PMID 25828348, PMID 27514751
2023 (1), R01HL133240 (1), R01HL139365 (1)